An expanding knowledge of the mechanisms and effects of alcohol consumption on cardiovascular disease

Journal of Cardiopulmonary Rehabilitation and Prevention

Volumn 34, Issue 3, 2014, Pages 159-171

  Matsumoto, Chisa ^a   Miedema, Michael D ^a,b   Ofman, Peter ^a,b   Gaziano, J Michael ^a,b   Sesso, Howard D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

alcohol; cardiovascular disease; coronary heart disease; prevention

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ALCOHOL; ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE (NAD(P)+); CENTRAL DEPRESSANT AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ALCOHOLIC CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; AGE; BLOOD; CARDIOVASCULAR DISEASES; CHEMICALLY INDUCED; COUNSELING; DIABETES MELLITUS, TYPE 2; DOSE RESPONSE; DRINKING BEHAVIOR; EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETICS; INSULIN RESISTANCE; LIFESTYLE; RISK ASSESSMENT; SEX DIFFERENCE; STROKE; SUBARACHNOID HEMORRHAGE;

AGE FACTORS; ALCOHOL DEHYDROGENASE; ALCOHOL DRINKING; ALDEHYDE OXIDOREDUCTASES; CARDIOVASCULAR DISEASES; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CONFOUNDING FACTORS (EPIDEMIOLOGY); COUNSELING; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN RESISTANCE; LIFE STYLE; PUBLIC HEALTH; RISK ASSESSMENT; SEX FACTORS; STROKE; SUBARACHNOID HEMORRHAGE;

EID: 84899918053     PISSN: 19327501     EISSN: 1932751X     Source Type: Journal    
DOI: 10.1097/HCR.0000000000000042     Document Type: Review

References (105)

1. Maclure M. Alcohol intake and risk of myocardial infarction. N Engl J Med. 1994; 330: 1241; author reply 1242.
2. Gaziano JM, Hennekens CH, Godfried SL, et al. Type of alcoholic beverage and risk of myocardial infarction. Am J Cardiol. 1999; 83: 52-57.
3. Pearson TA. Alcohol and heart disease. Circulation. 1996; 94: 3023-3025.
4. Krauss RM, Eckel RH, Howard B, et al. AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation. 2000; 102: 2284-2299.
5. Alcohol and the heart in perspective. Sensible limits reaffirmed. A Working Group of the Royal Colleges of Physicians, Psychiatrists and General Practitioners. J R Coll Physicians Lond. 1995; 29: 266-271.
6. Thun MJ, Peto R, Lopez AD, et al. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med. 1997; 337: 1705-1714.
7. Renaud SC, Gueguen R, Schenker J, d'Houtaud A. Alcohol and mortality in middle-aged men from easter n France. Epidemiology. 1998; 9: 184-188.
8. Waskiewicz A, Sygnowska E, Drygas W. Relationship between alcohol consumption and cardiovascular mortality-the Warsaw Pol-MONICA Project. Kardiol Pol. 2004; 60: 552-562; discussion 563.
9. Gaziano JM, Gaziano TA, Glynn RJ, et al. Light-to-moderate alcohol consumption and mortality in the Physicians' Health Study enrollment cohort. J Am Coll Cardiol. 2000; 35: 96-105.
10. Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali W A. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011; 342: d671.
11. Keil U, Chambless LE, Doring A, Filipiak B, Stieber J. The relation of alcohol intake to coronary heart disease and all-cause mortality in a beer-drinking population. Epidemiology. 1997; 8: 150-156.
12. Hammar N, Romelsjo A, Alfredsson L. Alcohol consumption, drinking pattern and acute myocardial infarction. A case referent study based on the Swedish Twin Register. J Intern Med. 1997; 241: 125-131.
13. Camargo CA Jr, Stampfer MJ, Glynn RJ, et al. Moderate alcohol consumption and risk for angina pectoris or myocardial infarction in U.S. male physicians. Ann Intern Med. 1997; 126: 372-375.
14. Gartside PS, Wang P, Glueck CJ. Prospective assessment of coronary heart disease risk factors: the NHANES I epidemio-logic follow-up study (NHEFS) 16-year follow-up. J Am Coll Nutr. 1998; 17: 263-269.
15. Rehm JT, Bondy SJ, Sempos CT, Vuong CV. Alcohol consumption and coronary heart disease morbidity and mortality. Am J Epidemiol. 1997; 146: 495-501.
16. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to alcohol consumption: a prospective study among male British doctors. Int J Epidemiol. 2005; 34: 199-204.
17. Wannamethee SG, Shaper AG. Type of alcoholic drink and risk of major coronary heart disease events and all-cause mortality. Am J Public Health. 1999; 89: 685-690.
18. Marques-Vidal P, Montaye M, Arveiler D, et al. Alcohol consumption and cardiovascular disease: differential effects in France and Northern Ireland. The PRIME study. Eur J Cardiovasc Prev Rehabil. 2004; 11: 336-343.
19. Makita S, Onoda T, Ohsawa M, et al. Influence of mild-to-moderate alcohol consumption on cardiovascular diseases in men from the general population. Atherosclerosis. 2012; 224: 222-227.
20. Reynolds K, Lewis B, Nolen JD, Kinney GL, Sathya B, He J. Alcohol consumption and risk of stroke: a meta-analysis. JAMA. 2003; 289: 579-588.
21. Feigin VL, Rinkel GJ, Lawes CM, et al. Risk factors for suba-rachnoid hemorrhage: an updated systematic review of epide-miological studies. Stroke. 2005; 36: 2773-2780.
22. Berger K, Ajani UA, Kase CS, et al. Light-to-moderate alcohol consumption and risk of stroke among U.S. male physicians. N Engl J Med. 1999; 341: 1557-1564.
23. Sacco RL, Elkind M, Boden-Albala B, et al. The protective effect of moderate alcohol consumption on ischemic stroke. JAMA. 1999; 281: 53-60.
24. Walsh CR, Larson MG, Evans JC, et al. Alcohol consumption and risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med. 2002; 136: 181-191.
25. Bryson CL, Mukamal KJ, Mittleman MA, et al. The association of alcohol consumption and incident heart failure: the Cardiovascular Health Study. J Am Coll Cardiol. 2006; 48: 305-311.
26. Djousse L, Gaziano JM. Alcohol consumption and risk of heart failure in the Physicians' Health Study I. Circulation. 2007; 115: 34-39.
27. George A, Figueredo VM. Alcoholic cardiomyopathy: a review. J Card Fail. 2011; 17: 844-849.
28. Segel LD, Klausner SC, Gnadt JT, Amsterdam EA. Alcohol and the heart. Med Clin North Am. 1984; 68: 147-161.
29. Cooper HA, Exner DV, Domanski MJ. Light-to-moderate alcohol consumption and prognosis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2000; 35: 1753-1759.
30. Greenspon AJ, Schaal SF. The "holiday heart": electrophysio-logic studies of alcohol effects in alcoholics. Ann Intern Med. 1983; 98: 135-139.
31. Rich EC, Siebold C, Campion B. Alcohol-related acute atrial fibrillation. A case-control study and review of 40 patients. Arch Intern Med. 1985; 145: 830-833.
32. Frost L, Vestergaard P. Alcohol and risk of atrial fibrillation or flutter: a cohort study. Arch Intern Med. 2004; 164: 1993-1998.
33. Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997; 96: 2455-2461.
34. Djousse L, Levy D, Benjamin EJ, et al. Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. Am J Cardiol. 2004; 93: 710-713.
35. Mukamal KJ, Tolstrup JS, Friberg J, Jensen G, Gronbaek M. Alcohol consumption and risk of atrial fibrillation in men and women: the Copenhagen City Heart Study. Circulation. 2005; 112: 1736-1742.
36. Djousse L, Levy D, Murabito JM, Cupples LA, Ellison RC. Alcohol consumption and risk of intermittent claudication in the Framingham Heart Study. Circulation. 2000; 102: 3092-3097.
37. Camargo CA Jr, Stampfer MJ, Glynn RJ, et al. Prospective study of moderate alcohol consumption and risk of peripheral arterial disease in US male physicians. Circulation. 1997; 95: 577-580.
38. Ciccarone E, Di Castelnuovo A, Salcuni M, et al. A high-score Mediterranean dietary pattern is associated with a reduced risk of peripheral arterial disease in Italian patients with type 2 diabetes. J Thromb Haemost. 2003; 1: 1744-1752.
39. Beulens JW, Algra A, Soedamah-Muthu SS, et al. Alcohol consumption and risk of recurrent cardiovascular events and mortality in patients with clinically manifest vascular disease and diabetes mellitus: the Second Manifestations of ARTerial (SMART) disease study. Atherosclerosis. 2010; 212: 281-286.
40. Arndt V, Rothenbacher D, Krauledat R, Daniel U, Brenner H. Age, alcohol consumption, and all-cause mortality. Ann Epidemiol. 2004; 14: 750-753.
41. Simons LA, McCallum J, Friedlander Y, Simons J. Alcohol intake and survival in the elderly: a 77 month follow-up in the Dubbo study. Aust N Z J Med. 1996; 26: 662-670.
42. Fuchs CS, Stampfer MJ, Colditz GA, et al. Alcohol consumption and mortality among women. N Engl J Med. 1995; 332: 1245-1250.
43. Kaufman DW, Rosenberg L, Helmrich SP, Shapiro S. Alcoholic beverages and myocardial infarction in young men. Am J Epidemiol. 1985; 121: 548-554.
44. Tanasescu M, Hu FB. Alcohol consumption and risk of coronary heart disease among individuals with type 2 diabetes. Curr Diab Rep. 2001; 1: 187-191.
45. Muntwyler J, Hennekens CH, Buring JE, Gaziano JM. Mortality and light to moderate alcohol consumption after myocardial infarction. Lancet. 1998; 352 (9144): 1882-1885.
46. Shaper AG, Wannamethee SG. Alcohol intake and mortality in middle aged men with diagnosed coronary heart disease. Heart. 2000; 83: 394-399.
47. Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA. Prior alcohol consumption and mortality following acute myocardial infarction. JAMA. 2001; 285: 1965-1970.
48. Shaper AG, Wannamethee G, Walker M. Alcohol and mortality in British men: explaining the U-shaped curve. Lancet. 1988; 2 (8623): 1267-1273.
49. Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali W A. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. BMJ. 2011; 342: d636.
50. Brinton EA. Effects of ethanol intake on lipoproteins. Curr Atheroscler Rep. 2012; 14: 108-114.
51. Muth ND, Laughlin GA, von Muhlen D, Smith SC, Barrett-Connor E. High-density lipoprotein subclasses are a potential intermediary between alcohol intake and reduced risk of cardiovascular disease: the Rancho Bernardo Study. Br J Nutr. 2010; 104: 1034-1042.
52. Roerecke M, Rehm J. The cardioprotective association of average alcohol consumption and ischaemic heart disease: a systematic review and meta-analysis. Addiction. 2012; 107: 1246-1260.
53. Hillbom M, Saloheimo P, Juvela S. Alcohol consumption, blood pressure, and the risk of stroke. Curr Hypertens Rep. 2011; 13: 208-213.
54. Wakabayashi I, Groschner K. Modification of the association between alcohol drinking and non-HDL cholesterol by gender. Clin Chim Acta. 2009; 404: 154-159.
55. Tolstrup JS, Gronbaek M, Nordestgaard BG. Alcohol intake, myocardial infarction, biochemical risk factors, and alcohol dehydrogenase genotypes. Circ Cardiovasc Genet. 2009; 2: 507-514.
56. Corella D, Portoles O, Arriola L, et al. Saturated fat intake and alcohol consumption modulate the association between the APOE polymorphism and risk of future coronary heart disease: a nested case-control study in the Spanish EPIC cohort. J Nutr Biochem. 2011; 22: 487-494.
57. Perissinotto E, Buja A, Maggi S, et al. Alcohol consumption and cardiovascular risk factors in older lifelong wine drinkers: the Italian Longitudinal Study on Aging. Nutr Metab Cardiovasc Dis. 2010; 20: 647-655.
58. Yin RX, Li YY, Liu WY, Zhang L, Wu JZ. Interactions of the apolipoprotein A5 gene polymorphisms and alcohol consumption on serum lipid levels. PLoS One. 2011; 6: e17954.
59. de Lorimier AA. Alcohol, wine, and health. Am J Surg. 2000; 180: 357-361.
60. Taylor B, Irving HM, Baliunas D, et al. Alcohol and hypertension: gender differences in dose-response relationships determined through systematic review and meta-analysis. Addiction. 2009; 104: 1981-1990.
61. Zilkens RR, Burke V, Hodgson JM, Barden A, Beilin LJ, Puddey IB. Red wine and beer elevate blood pressure in normotensive men. Hypertension. 2005; 45: 874-879.
62. Mahmud A, Feely J. Divergent effect of acute and chronic alcohol on arterial stiffness. Am J Hypertens. 2002; 15: 240-243.
63. Davies MJ, Baer DJ, Judd JT, Brown ED, Campbell WS, Taylor PR. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopau-sal women: a randomized controlled trial. JAMA. 2002; 287: 2559-2562.
64. Maraldi C, Volpato S, Kritchevsky SB, et al. Impact of inflammation on the relationship among alcohol consumption, mortality, and cardiac events: the health, aging, and body composition study. Arch Intern Med. 2006; 166: 1490-1497.
65. Sierksma A, Patel H, Ouchi N, et al. Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity. Diabetes Care. 2004; 27: 184-189.
66. Harding AH, Sargeant LA, Khaw KT, et al. Cross-sectional association between total level and type of alcohol consumption and glycosylated haemoglobin level: the EPIC-Norfolk Study. Eur J Clin Nutr. 2002; 56: 882-890.
67. Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett WC. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ. 1995; 310 (6979): 555-559.
68. Koppes LL, Dekker JM, Hendriks HF, Bouter LM, Heine RJ. Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care. 2005; 28: 719-725.
69. Shai I, Wainstein J, Harman-Boehm I, et al. Glycemic effects of moderate alcohol intake among patients with type 2 diabetes: a multicenter, randomized, clinical intervention trial. Diabetes Care. 2007; 30: 3011-3016.
70. Beulens JW, van Beers RM, Stolk RP, Schaafsma G, Hendriks HF. The effect of moderate alcohol consumption on fat distribution and adipocytokines. Obesity (Silver Spring). 2006; 14: 60-66.
71. Beulens JW, de Zoete EC, Kok FJ, Schaafsma G, Hendriks HF. Effect of moderate alcohol consumption on adipokines and insulin sensitivity in lean and overweight men: a diet intervention study. Eur J Clin Nutr. 2008; 62: 1098-1105.
72. Imhof A, Plamper I, Maier S, Trischler G, Koenig W. Effect of drinking on adiponectin in healthy men and women: a randomized intervention study of water, ethanol, red wine, and beer with or without alcohol. Diabetes Care. 2009; 32: 1101-1103.
73. Hines LM, Hunter DJ, Stampfer MJ, et al. Alcohol consumption and high-density lipoprotein levels: the effect of ADH1C genotype, gender and menopausal status. Atherosclerosis. 2005; 182: 293-300.
74. Chang YC, Chiu YF, Lee IT, et al. Common ALDH2 genetic variants predict development of hypertension in the SAPPHIRe prospective cohort: gene-environmental interaction with alcohol consumption. BMC Cardiovasc Disord. 2012;12:58.
75. Heidrich J, Wellmann J, Doring A, Illig T, Keil U. Alcohol consumption, alcohol dehydrogenase and risk of coronary heart disease in the MONICA/KORA-Augsburg cohort 1994/1995-2002. Eur J Cardiovasc Prev Rehabil. 2007; 14: 769-774.
76. Jensen MK, Rimm EB, Rader D, et al. S447X variant of the lipoprotein lipase gene, lipids, and risk of coronary heart disease in 3 prospective cohort studies. Am Heart J. 2009; 157: 384-390.
77. Whitfield JB, O'Brien ME, Nightingale BN, Zhu G, Heath AC, Martin NG. ADH genotype does not modify the effects of alcohol on high-density lipoprotein. Alcohol Clin Exp Res. 2003; 27: 509-514.
78. Salem RO, Laposata M. Effects of alcohol on hemostasis. Am J Clin Pathol. 2005; 123 (Suppl): S96-S105.
79. Collins MA, Neafsey EJ, Mukamal KJ, et al. Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies. Alcohol Clin Exp Res. 2009; 33: 206-219.
80. Wannamethee SG, Lowe GD, Shaper G, et al. The effects of different alcoholic drinks on lipids, insulin and haemostatic and inflammatory markers in older men. Thromb Haemost. 2003; 90: 1080-1087.
81. Zhang QH, Das K, Siddiqui S, Myers AK. Effects of acute, moderate ethanol consumption on human platelet aggregation in platelet-rich plasma and whole blood. Alcohol Clin Exp Res. 2000; 24: 528-534.
82. Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ, Hennekens CH. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA. 1994; 272: 929-933.
83. Suzuki K, Elkind MS, Boden-Albala B, et al. Moderate alcohol consumption is associated with better endothelial function: a cross sectional study. BMC Cardiovasc Disord. 2009;9:8.
84. Teragawa H, Fukuda Y, Matsuda K, et al. Effect of alcohol consumption on endothelial function in men with coronary artery disease. Atherosclerosis. 2002; 165: 145-152.
85. Wang JJ, Tung TH, Yin WH, et al. Effects of moderate alcohol consumption on inflammatory biomarkers. Acta Cardiol. 2008; 63: 65-72.
86. Avellone G, Di Garbo V, Campisi D, et al. Effects of moderate Sicilian red wine consumption on inflammatory biomarkers of atherosclerosis. Eur J Clin Nutr. 2006; 60: 41-47.
87. Albert MA, Glynn RJ, Ridker PM. Alcohol consumption and plasma concentration of C-reactive protein. Circulation. 2003; 107: 443-447.
88. Arranz S, Chiva-Blanch G, Valderas-Martinez P, Medina-Remon A, Lamuela-Raventos RM, Estruch R. Wine, beer, alcohol and polyphenols on cardiovascular disease and cancer. Nutrients. 2012; 4: 759-781.
89. Estruch R, Sacanella E, Mota F, et al. Moderate consumption of red wine, but not gin, decreases erythrocyte superoxide dis-mutase activity: a randomised cross-over trial. Nutr Metab Cardiovasc Dis. 2011; 21: 46-53.
90. Huang PH, Chen YH, Tsai HY, et al. Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bio-availability. Arterioscler Thromb Vasc Biol. 2010; 30: 869-877.
91. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ. 1999; 319 (7224): 1523-1528.
92. Kagan A, Yano K, Rhoads GG, McGee DL. Alcohol and cardiovascular disease: the Hawaiian experience. Circulation. 1981; 64 (3 Pt 2): III 27-III 31.
93. Kitamura A, Iso H, Sankai T, et al. Alcohol intake and premature coronary heart disease in urban Japanese men. Am J Epidemiol. 1998; 147: 59-65.
94. Klatsky AL, Armstrong MA, Friedman GD. Red wine, white wine, liquor, beer, and risk for coronary artery disease hospi-talization. Am J Cardiol. 1997; 80: 416-420.
95. Rosenbloom JI, Mukamal KJ, Frost LE, Mittleman MA. Alcohol consumption patterns, beverage type, and long-term mortality among women survivors of acute myocardial infarction. Am J Cardiol. 2012; 109: 147-152.
96. Suhonen O, Aromaa A, Reunanen A, Knekt P. Alcohol consumption and sudden coronary death in middle-aged Finnish men. Acta Med Scand. 1987; 221: 335-341.
97. Kauhanen J, Kaplan GA, Goldberg DE, Salonen JT. Beer bing-ing and mortality: results from the Kuopio ischaemic heart disease risk factor study, a prospective population based study. BMJ. 1997; 315 (7112): 846-851.
98. Graff-Iversen S, Jansen MD, Hoff DA, et al. Divergent associations of drinking frequency and binge consumption of alcohol with mortality within the same cohort. J Epidemiol Community Health. 2013; 67: 350-357.
99. McElduff P, Dobson AJ. How much alcohol and how often? Population based case-control study of alcohol consumption and risk of a major coronary event. BMJ 1997;314 (7088): 1159-1164.
100. Rimm EB, Giovannucci EL, Willett WC, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet. 1991; 338 (8765): 464-468.
101. Goldberg IJ, Mosca L, Piano MR, Fisher EA. AHA Science Advisory: Wine and your heart: a science advisory for healthcare professionals. Circulation. 2001; 103: 472-475.
102. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. Circulation. 2011; 123: 1243-1262.
103. Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012; 33: 1635-1701.
104. US Drinking Rate Edges Up Slightly to 25-Year High. Gallup Poll. http://www.gallup.com/poll/141656/drinking-rate-edges-slightly-year-high.aspx.
105. Fiumara K, Goldhaber SZ. Cardiology patient pages. A patient's guide to taking Coumadin/warfarin. Circulation. 2009; 119: e220-222.